Zecotek to Attend the 2014 CanTech Investment Conference in Toronto, Canada
Singapore, January 13, 2014 – Zecotek Photonics Inc. (TSX-V: ZMS; OTCPK: ZMSPF; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company will be attending the 2014 Cantech Investment Conference on January 16, 2014 in Toronto, Ontario. Dr. A. Faouzi Zerrouk, Chairman, President, and CEO of Zecotek will be presenting at the conference at 11:25am EST. The Company will also have a booth in the investor`s exhibit hall.
This is a one day investment conference which brings institutional and retail investors together with Canada`s leading technology companies at the Metro Toronto Convention Centre. It is the ultimate showcase for Canadian technology development and investor opportunities. Canadian icon Commander Chris Hadfield will take the stage as key note speaker to remind Canadians that “The Sky is Not the Limit”. Other speakers include Canadian tech legend Sir Terry Matthews, Wellington Financial CEO Mark McQueen, and OMERS Ventures CEO John Ruffolo.
The day will complete with Cantech Letter’s 4th annual Cantech Letter Awards Dinner,recognizing the top achievement in Canadian technology, clean technology and life science sectors.
For conference information please visit: www.cambridgehouse.com.
– 30 –
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Laser Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners such as Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), and National NanoFab Center (South Korea). For more information visit Zecotek Photonics, follow @zecotek on Twitter and “like” us in Facebook.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
Zecotek Photonics Inc.
T: (604) 783-8291
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at Zecotek Photonics.